Argenx Se (ARGX) Tax Provisions (2017 - 2026)
Argenx Se's (ARGX) quarterly Tax Provisions came in at $59.0 million in Q2 2026, down 44.86% YoY from $107.0 million in Q2 2025, and down 1.67% on a QoQ basis from $60.0 million in Q1 2026.
Argenx Se (ARGX) Tax Provisions (2017 - 2026) Analysis & Trends
Argenx Se (ARGX) has 8 years of Tax Provisions data on file, last reported at $59.0 million in Q2 2026.
- Quarterly Tax Provisions fell 44.86% year-over-year to $59.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $193.0 million (up 206.9% YoY) and the FY2025 annual result came in at -$13.4 million, up 98.2% from the prior year.
- Tax Provisions fell to $59.0 million in Q2 2026, from $60.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $107.0 million in Q2 2025 to a low of -$33.0 million in Q1 2025.
- A 3-year average of $30.3 million and a median of $36.5 million in 2022 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 281.82% in 2026, down 44.86% in 2026.
- Tracing ARGX's Tax Provisions over 3 years: stood at -$25.2 million in 2022, then jumped by 524.89% to $107.0 million in 2025, then sank by 44.86% to $59.0 million in 2026.
- The last three Tax Provisions figures came in at $59.0 million (Q2 2026), $60.0 million (Q1 2026), and $107.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.00 Mn |
| Mar 31, 2026 | 60.00 Mn |
| Jun 30, 2025 | 107.00 Mn |
| Mar 31, 2025 | -33.00 Mn |
| Jun 30, 2022 | -25.18 Mn |
| Mar 31, 2022 | 14.07 Mn |
| Jun 30, 2021 | -24.02 Mn |
| Mar 31, 2021 | 11.18 Mn |
| Dec 31, 2020 | 82,268.00 |
| Sep 30, 2020 | 530,307.07 |
| Jun 30, 2020 | 1.29 Mn |
| Mar 31, 2020 | -1.20 Mn |
| Dec 31, 2019 | 353,097.17 |
| Sep 30, 2019 | 4.54 Mn |
| Jun 30, 2019 | 595,528.72 |
| Mar 31, 2019 | -204,593.20 |
| Dec 31, 2018 | 869,744.08 |
| Sep 30, 2018 | 73,277.14 |
| Jun 30, 2018 | -36,996.78 |
| Dec 31, 2017 | 1.41 Mn |